Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway.
Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway.
复制标题
汉黄芩苷通过 PI3K/Akt 通路抑制 NF-kappa B 激活,预防炎症相关微环境中结肠炎相关结直肠癌发生和结肠癌进展
DOI:
10.18632/oncotarget.8815
复制
发表时间:
2016-06-07
期刊:
影响因子:
--
通讯作者:
Lu N
中科院分区:
文献类型:
--
作者:
Sun Y;Zhao Y;Wang X;Zhao L;Li W;Ding Y;Kong L;Guo Q;Lu N
The inflammatory microenvironment has been reported to be correlated with tumor initiation and malignant development. In the previous studies we have found that wogonoside exerts anti-neoplastic and anti-inflammatory activities. In this study, we aimed to further investigate the chemopreventive effects of wogonoside on colitis-associated cancer and delineated the potential mechanisms. In the azoxymethane initiated and dextran sulfate sodium (AOM/DSS) promoted colorectal carcinogenesis mouse model, wogonoside significantly reduced the disease severity, lowered tumor incidence and inhibited the development of colorectal adenomas. Moreover, wogonoside inhibited inflammatory cells infiltration and cancer cell proliferation at tumor site. Furthermore, wogonoside dramatically decreased the secretion and expression of IL-1β, IL-6 and TNF-α as well as the nuclear expression of NF-κB in adenomas and surrounding tissues. In vitro results showed that wogonoside suppressed the proliferation of human colon cancer cells in the inflammatory microenvironment. Mechanistically, we found that wogonoside inhibited NF-κB activation via PI3K/Akt pathway. In conclusion, our results demonstrated that wogonoside attenuated colitis-associated tumorigenesis in mice and inhibited the progression of human colon cancer in inflammation-related microenvironment via suppressing NF-κB activation by PI3K/Akt pathway, indicating that wogonoside could be a promising therapeutic agent for colorectal cancer.
登录
查看更多内容
影响因子:
3.5
作者:
Kanno, Syu-ichi;Tomizawa, Ayako;Ishikawa, Masaaki
通讯作者:
Ishikawa, Masaaki
DOI:
10.1007/s00432-009-0705-2
发表时间:
2010-05-01
影响因子:
3.6
作者:
Gao, Ying;Lu, Na;Guo, Qinglong
通讯作者:
Guo, Qinglong
影响因子:
3
作者:
Klampfer L
通讯作者:
Klampfer L
影响因子:
20.3
作者:
Chen, Yan;Hui, Hui;Guo, Qinglong
通讯作者:
Guo, Qinglong
影响因子:
5.3
作者:
LAROSA, FA;PIERCE, JW;SONENSHEIN, GE
通讯作者:
SONENSHEIN, GE